論文 - 詳細
| RRC ID | 44014 |
|---|---|
| 著者 | Zhu Q, Shibata T, Kabashima T, Kai M. |
| タイトル | Inhibition of HIV-1 protease expression in T cells owing to DNA aptamer-mediated specific delivery of siRNA. |
| ジャーナル | Eur J Med Chem |
| Abstract |
Targeted delivery is a promising way to improve the safety and efficiency of siRNA delivery. We show that a DNA aptamer could be used to deliver siRNA into CD4(+) T cells specifically. The DNA aptamer was obtained from the conversion of a reported RNA aptamer that binds to CD4 protein on the surface of T cells. It was covalently conjugated to the sense strand of the siRNA targeting HIV-1 protease (HIV-PR). The resulting DNA aptamer-siRNA chimera could specifically enter into CD4(+) T cells and efficiently knock down the expression of exogenous HIV-PR gene. This study provides the first evidence that the DNA aptamer with intrinsic stability has a greater potential to be used for siRNA delivery. |
| 巻・号 | 56 |
| ページ | 396-9 |
| 公開日 | 2012-10-1 |
| DOI | 10.1016/j.ejmech.2012.07.045 |
| PII | S0223-5234(12)00471-0 |
| PMID | 22907035 |
| MeSH | Aptamers, Nucleotide / metabolism* CD4-Positive T-Lymphocytes / metabolism* Drug Delivery Systems* Gene Expression Regulation, Enzymologic / drug effects* Gene Expression Regulation, Enzymologic / genetics HIV Protease / genetics HIV Protease / metabolism* Protease Inhibitors / chemical synthesis Protease Inhibitors / chemistry Protease Inhibitors / pharmacology* RNA, Small Interfering / genetics RNA, Small Interfering / metabolism RNA, Small Interfering / pharmacology* |
| IF | 5.573 |
| 引用数 | 31 |
| WOS 分野 | CHEMISTRY, MEDICINAL |
| オルトメトリクス指標 |
オルトメトリクス指標項目
|
| 最多言及媒体 | Patent(IFI CLAIMS) |
| 各媒体での言及数の合計 | 2 |
| 過去6か月間でのオルトメトリクス指標の変動値 | 0.0 |
| リソース情報 | |
| ヒト・動物細胞 | |